APA (7th ed.) Citation

E, W., K, B., J, W., A, T., & A, Z. (2018). Analysis of haemostasis biomarkers in patients with advanced stage lung cancer during hypofractionated radiotherapy treatment. The Journal of international medical research, 46(5), 1876. https://doi.org/10.1177/0300060517750976

Chicago Style (17th ed.) Citation

E, Wolny-Rokicka, Brzeźniakiewicz-Janus K, Wydmański J, Tukiendorf A, and Zembroń-Łacny A. "Analysis of Haemostasis Biomarkers in Patients with Advanced Stage Lung Cancer During Hypofractionated Radiotherapy Treatment." The Journal of International Medical Research 46, no. 5 (2018): 1876. https://doi.org/10.1177/0300060517750976.

MLA (9th ed.) Citation

E, Wolny-Rokicka, et al. "Analysis of Haemostasis Biomarkers in Patients with Advanced Stage Lung Cancer During Hypofractionated Radiotherapy Treatment." The Journal of International Medical Research, vol. 46, no. 5, 2018, p. 1876, https://doi.org/10.1177/0300060517750976.